# Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term

> **NCT05284357** · — · UNKNOWN · sponsor: **FX Solutions** · enrollment: 416 (estimated)

## Conditions studied

- Shoulder Disease
- Shoulder Fractures
- Shoulder Arthroplasty for Revision of Previous Treatment

## Interventions

- **DEVICE:** Shoulder Arthroplasty Surgery with HUMELOCK I & II® Anatomic Shoulder System
- **DEVICE:** Shoulder Arthroplasty Surgery with HUMELOCK II® Reversible System
- **DEVICE:** Shoulder Arthroplasty Surgery with HUMELOCK Reversed® Shoulder System
- **DEVICE:** Shoulder Arthroplasty Surgery with EASYTECH® Anatomic Shoulder System
- **DEVICE:** Shoulder Arthroplasty Surgery with EASYTECH® Reversed System (Primary intention)
- **DEVICE:** Shoulder Arthroplasty Surgery with EASYTECH® Reversible System (for revision only)
- **DEVICE:** Shoulder Arthroplasty Surgery with HUMERIS® Anatomic Shoulder System
- **DEVICE:** Shoulder Arthroplasty Surgery with HUMERIS® Reversible Shoulder System

## Key facts

- **NCT ID:** NCT05284357
- **Lead sponsor:** FX Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-07
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 416 (ESTIMATED)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05284357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05284357, "Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT05284357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*